Literature DB >> 20594600

Serotonin 1A receptor gene, schizophrenia and bipolar disorder: an association study and meta-analysis.

Taro Kishi1, Tomo Okochi, Tomoko Tsunoka, Takenori Okumura, Tsuyoshi Kitajima, Kunihiro Kawashima, Yoshio Yamanouchi, Yoko Kinoshita, Hiroshi Naitoh, Toshiya Inada, Hiroshi Kunugi, Tadafumi Kato, Takeo Yoshikawa, Hiroshi Ujike, Norio Ozaki, Nakao Iwata.   

Abstract

Several investigations have reported associations between serotonin 1A (5-HT1A) receptor and major psychiatric disorders, such as schizophrenia and bipolar disorder (BP), making the 5-HT1A receptor gene (HTR1A) a good candidate gene for the pathophysiology of schizophrenia and BP. To evaluate the association between HTR1A and schizophrenia and BP, we conducted a case-control study of Japanese population samples with two single- nucleotide polymorphisms (SNPs), including rs6295 (C-1019G) in HTR1A. In addition, we conducted a meta-analysis of rs6295, which has been examined in other studies. Using one functional single- nucleotide polymorphism (SNP; rs6295) and one tagging SNP (rs878567), we conducted a genetic association analysis of case-control samples (857 schizophrenic patients, 1028 BP patients and 1810 controls) in the Japanese population. Two association studies for schizophrenia and three association studies for BP, including this study, met our criteria for the meta-analysis of rs6295. We found an association between HTR1A and Japanese BP in a haplotype-wise analysis, the significance of which remained after Bonferroni correction. In addition, we detected an association between rs6295 and BP in the meta-analysis (fixed model: P(Z)=0.000400). However, we did not detect an association between HTR1A and schizophrenia in the allele/genotype-wise, haplotype-wise or meta-analysis. HTR1A may play an important role in the pathophysiology of BP, but not schizophrenia in the Japanese population. In the meta-analysis, rs6295 in HTR1A was associated with BP patients. Crown
Copyright © 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20594600     DOI: 10.1016/j.psychres.2010.06.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  19 in total

Review 1.  Genetic, epigenetic and posttranscriptional mechanisms for treatment of major depression: the 5-HT1A receptor gene as a paradigm

Authors:  Paul R. Albert; Brice Le François; Faranak Vahid-Ansari
Journal:  J Psychiatry Neurosci       Date:  2019-05-01       Impact factor: 6.186

2.  The serotonin 1A receptor gene in mood disorders: a tale of missed opportunities.

Authors:  Philipp G Sand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-20       Impact factor: 5.270

Review 3.  Transcriptional regulation of the 5-HT1A receptor: implications for mental illness.

Authors:  Paul R Albert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

4.  Neuropsychiatric and behavioral profiles of 2 adults with williams syndrome: response to antidepressant intake.

Authors:  Diego Urgeles; Victoria Alonso; Tania Ramos-Moreno
Journal:  Prim Care Companion CNS Disord       Date:  2013-08-01

Review 5.  Molecular and genetic basis of depression.

Authors:  Madhumita Roy; Madhu G Tapadia; Shobhna Joshi; Biplob Koch
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

Review 6.  The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder.

Authors:  Taro Kishi; Reiji Yoshimura; Yasuhisa Fukuo; Tomo Okochi; Shinji Matsunaga; Wakako Umene-Nakano; Jun Nakamura; Alessandro Serretti; Christoph U Correll; John M Kane; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-07-03       Impact factor: 5.270

7.  High-resolution chromosome ideogram representation of recognized genes for bipolar disorder.

Authors:  Lindsay N Douglas; Austen B McGuire; Ann M Manzardo; Merlin G Butler
Journal:  Gene       Date:  2016-04-07       Impact factor: 3.688

8.  Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.

Authors:  Allison C Nugent; Paul J Carlson; Earle E Bain; William Eckelman; Peter Herscovitch; Husseini Manji; Carlos A Zarate; Wayne C Drevets
Journal:  J Psychopharmacol       Date:  2013-08-07       Impact factor: 4.153

Review 9.  Transcriptional dys-regulation in anxiety and major depression: 5-HT1A gene promoter architecture as a therapeutic opportunity.

Authors:  Paul R Albert; Laura M Fiori
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

10.  Neural markers of errors as endophenotypes in neuropsychiatric disorders.

Authors:  Dara S Manoach; Yigal Agam
Journal:  Front Hum Neurosci       Date:  2013-07-18       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.